Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for
Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on 'Drugs to Fight Cardiovascular Damage'.
The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical
 |
| Radboud University Medical Centre, Nijmegen |
Center in Nijmegen in the Netherlands.
This EACPT cardiovascular focus meeting is of interest to clinical
pharmacologists, pharmacologists, and other young scientists
and clinicians interested in drug treatment of cardiovascular disease.
Topics include:
- ultrasound imaging of vascular
injury (including a workshop tproviding t hands-on training),
- the microbiome and
inflammation in the metabolic syndrome
- targeting inflammation to prevent
and treat atherosclerosis
- diagnosis and therapy of adrenal
hypertension
- protection against ischaemia-reperfusion injury.
Provisional State of the Art Lectures by invited speakers include:
Arterial stiffness measurements; methods
and relevance for risk assessment and drug-research: Stephane Laurent, Paris, France
IMT measurement with ultrasound, methods
and relevance for risk assessment and drug research: Luc van Bortel, Gent, Belgium
The microbiome in the pathogenesis of
metabolic syndrome: Max Nieuwdorp
Fat cells and inflammation in the
pathogenesis of the Metabolic Syndrome: Rinke Stienstra, Nijmegen, The
Netherlands
Predicting and manipulating drug
inactivation by the human gut microbiome: H. Haiser. FAS Center for Systems
Biology, Harvard University, USA
Cardiac protection by conditioning: from
bench to bedside: D. Hausenloy, Hatter Institute, London
The role of hexokinase in
cardioprotection: C. Zuurbier, Amsterdam, The Netherlands
Wnt pathways in cardiac repair and remodeling: M. Blankesteijn
Targeting the adaptive immune system in
atherosclerosis: Esther Lutgens, AMC, Amsterdam
Trained immunity in the pathogenesis of
atherosclerosis: Niels Riksen, Nijmegen, The Netherlands
The pathogenesis of autonomous adrenal
aldosterone release: Felix Beuschlein
Diagnosis and treatment of
hyperaldosteronism: Jaap Deinum, Nijmegen, The Netherlands
Health professional scientists, academics and professionals from the pharmaceutical, biotechnology, and related sectors are invited to submit their latest
scientific results for oral or poster presentation.
Abstract submission and registration will open shortly on our dedicated website.
